Why Is Corvus Pharmaceuticals Stock Soaring On Friday?

benzinga.com/25/05/45323117/corvus-pharmaceuticals-investigational-drug-shows-rapid-dose-dependent-efficacy-in-early-stage-eczema-trial

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) on Thursday released new interim data from the Phase 1 clinical trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis.
The data demonstrated a favorable safety and efficacy profile, including earlier and deeper…

This story appeared on benzinga.com, 2025-05-09 15:57:40.
The Entire Business World on a Single Page. Free to Use →